Innovative application of allosteric modulators of adenosine a1 receptors for the prevention and treatment of stroke and myocardial infarction

Información del proyecto

KOUROUNAKIS ANGELIKI

Identificador del acuerdo de subvención: QLK6-CT-1999-51170

Fecha de inicio 17 Enero 2000

Fecha de finalización 16 Enero 2001

Financiado con arreglo a

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coste total € 51 600,00

Aportación de la UE € 51 600,00

Coordinado por

ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece

Objetivo

Evaluation of a novel series of allosteric modulators, compounds that enhance adenosine A1 agonist binding and function, in combination with antioxidants, in in-vitro/in-vivo models of ischemic-reperfusion injury.

Ámbito científico

• medical and health sciences › basic medicine › neurology › stroke

Programa(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Tema(s)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Convocatoria de propuestas

Data not available

Régimen de financiación

RGI - Research grants (individual fellowships)

Coordinador

ARISTOTLE UNIVERSITY OF THESSALONIKI

• Aportación de la UE: Sin datos
• Dirección: University Building Administration Building ; 54006 THESSALONKI ; Grecia
• Coste total: Sin datos